Discovery, Inc. (NASDAQ: DISCA) Director John C. Malone Sells 124,839 Shares
Discovery, Inc. (NASDAQ: DISCA) Director John C. Malone sold 124,839 shares of the company in a trade on Thursday, June 3. The shares were sold at an average price of $ 29.68, for a total transaction of $ 3,705,221.52. The transaction was disclosed in a legal file with the Securities & Exchange Commission, accessible through this link.
NASDAQ DISCA shares traded down $ 0.08 at midday on Friday, reaching $ 31.55. The company’s shares had a trading volume of 5,104,910 shares, compared to its average volume of 14,197,398. The company has a 50-day simple moving average of $ 37.10. The company has a market cap of $ 15.94 billion, a PE ratio of 21.44, a P / E / G ratio of 1.28 and a beta of 1.37. The company has a quick ratio of 1.87, a current ratio of 1.87 and a debt ratio of 1.20. Discovery, Inc. has a one-year low at $ 19.07 and a one-year high at $ 78.14.
Discovery (NASDAQ: DISCA) last released its results on Wednesday, April 28. The company reported EPS of $ 0.21 for the quarter, missing Zacks’ consensus estimate of $ 0.61 ($ 0.40). The company posted revenue of $ 2.79 billion in the quarter, compared to $ 2.77 billion according to analysts’ estimates. Discovery had a net margin of 9.11% and a return on equity of 14.44%. Discovery’s quarterly revenue increased 4.1% year-over-year. In the same quarter of last year, the company made earnings per share of $ 0.87. As a group, stock analysts predict that Discovery, Inc. will post 2.36 EPS for the current fiscal year.
Several analysts recently commented on the title. Barclays upgraded Discovery’s shares from an “underweight” to an “equal weight” rating and raised its price target for the company from $ 34.00 to $ 35.00 in a report released on Friday May 7. Bank of America lifted Discovery’s stock from an “underperforming” rating to a “neutral” rating and set a price target of $ 40.00 on the stock in a report released Thursday, April 29. Deutsche Bank Aktiengesellschaft raised its price target for Discovery shares from $ 35 to $ 60.00 and gave the company a “buy” rating in a report released on Wednesday, April 7. They noted that the move was an appraisal call. Citigroup Inc. A 3% Russell Base Protected Minimum Coupon Upgraded Discovery Shares from a “Neutral” to a “Buy” Rating and Raised Their Target Price for the Company by $ 40.00 at $ 44.00 in a research note on Monday May 17th. Finally, TheStreet reduced Discovery’s actions from a “b” rating to a “c +” rating in a Wednesday April 28th research note. Twelve investment analysts rated the stock with a conservation rating and eight gave the stock a buy rating. The stock currently has an average hold rating and a consensus target price of $ 39.20.
Hedge funds and other institutional investors have recently changed their holdings in the company. Exchange Traded Concepts LLC purchased a new stake in Discovery shares in the first quarter valued at approximately $ 1,274,000. M&R Capital Management Inc. increased its holdings of Discovery shares by 6.8% in the first quarter. M&R Capital Management Inc. now owns 153,954 shares of the company valued at $ 6,690,000 after purchasing an additional 9,808 shares during the period. CWM Advisors LLC increased its holdings of Discovery shares by 37.3% in the first quarter. CWM Advisors LLC now owns 36,504 shares of the company valued at $ 1,586,000 after purchasing an additional 9,915 shares during the period. Patton Fund Management Inc. purchased a new equity interest in Discovery in the first quarter valued at approximately $ 1,297,000. Finally, Hartford Investment Management Co. increased its stake in Discovery by 11.0% during the fourth quarter. Hartford Investment Management Co. now owns 18,004 shares of the company valued at $ 542,000 after purchasing an additional 1,777 shares during the period. Institutional investors and hedge funds hold 40.56% of the company’s shares.
About the discovery
Discovery, Inc, a media company, provides content on various distribution platforms in approximately 50 languages around the world. It operates in two segments, US networks and international networks. The company owns and operates various television networks under Discovery Channel, HGTV, Food Network, TLC, Animal Planet, Investigation Discovery, Travel Channel, Science, MotorTrend, Discovery en Español, Discovery Familia, Eurosport, TVN, Discovery Kids, Discovery Family, American Heroes Channel, Destination America, Discovery Life, DIY Network, Cooking Channel, Great American Country, ID, Oprah Winfrey Network, Eurosport, DMAX and Discovery Home & Health brands, as well as other regional TV networks.
Recommended Story: What is the Bid-Ask Spread?
This instant news alert was powered by storytelling technology and MarketBeat financial data to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured article: How to invest in marijuana stocks
7 health actions serving innovation in 2021
We all knew that traditional health services were disrupted in 2020. The patient-doctor relationship has gone virtual. During the first months of the pandemic, many people in need of elective surgeries simply did not have this option available to them. And even local pharmacies have taken on a new role in e-commerce as curbside pickup or home delivery of prescription drugs has become the norm.
Unsurprisingly, healthcare stocks took a rough ride last year. Overall, the sector was down 11%, well below the S&P 500 which climbed more than 15%.
However, the market is always looking to the future with a particular eye on innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in the advanced testing phase for drugs that can deliver groundbreaking results for conditions that continue to plague our world.
This is the object of this presentation. We have identified 7 healthcare actions that offer innovative ideas that will help achieve better patient outcomes. And in some cases, it will completely revolutionize medicine. These are also the stocks that analysts watch.
Check out the “7 healthcare stocks offering innovation in 2021”.